TOP CORPORATE NEWS :- 19 Jul 2017

Corporate News

TOP Headlines:- 19 Jul 2017

Sun gains on USFDA nod for Paroxetine hydrochloride
Zee Ent gains on acquiring 51% stake in Fly-By-Wire
Aurobindo jumps on USFDA approval for gRenvela tablets
Ashok Leyland up on technological pact with Sun Mobility
Sun gains on USFDA nod for Paroxetine hydrochloride

Ashok Leyland up on technological pact with Sun Mobility
Ashok Leyland has formed a technical alliance with Sun Mobility, promoted by Chetan Maini, founder of Reva electric vehicle, and Uday Khemka, for producing and selling electric vehicles.
The first electric bus as a result of the alliance will be rolled out in 12-18 months. About Rs 100 crore of investment will be made jointly in the initial phase with a proto-type ready by January 2018.
The alliance will deliver a swappable smart battery solution. The initial customers for these electric vehicles are expected to be STUs (state transport undertakings) with whom Ashok Leyland has already commenced discussion.

Zee Ent gains on acquiring 51% stake in Fly-By-Wire
Zee Entertainment has acquired an additional 51% stake in aviation company Fly-By-Wire International for Rs1.4 crore – No material impact as investment is quite marginal given the huge cash on books.

HPCL, GAIL look for Rs2, 000 cr funds for petrochemical plant
Hindustan Petroleum Corporation Ltd ( HPCL) and GAIL (India) are looking for viability gap funding of Rs2,000 crore to set up a petrochemical plant (1mmt ethylene derivatives plant) at a cost of Rs32,000 crore at Kakinada (Andhra Pradesh).
This is sentimentally positive for HPCL and GAIL.

Aurobindo jumps on USFDA approval for gRenvela tablets
Shares of Aurobindo Pharma gained over 4% to Rs765.30 on NSE after the company got USFDA approval for gRenvela tablets (used to treat ailments related to kidney).
Market size for tablet form is $600+ mn and there will not be any competition at the moment apart from the innovator – Positive for Aurobindo; we expect the stock to get re-rated.

Sun gains on USFDA nod for Paroxetine hydrochloride
Sun gets USFDA nod for Paroxetine hydrochloride (gPaxil) oral tablets, used to treat depression, panic attacks, and obsessive-compulsive disorder (OCD), and anxiety disorders.

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide 2 days free trial to our client.Join our services and trade with us.

GET MORE DETAILS HERE:-
Commodity Market Tips

Nifty Future Tips

* INVESTMENT & TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISKS, PAST PERFORMANCE IS NOT A GUARANTEE OF FUTURE PERFORMANCE.
* CAPITALSTARS INVESTMENT ADVISER: SEBI REGISTRATION NUMBER: INA000001647
Advertisements